Cite

HARVARD Citation

    Alroughani, R. (2014). High discontinuation rate of natalizumab in JC virus seropositive patients due to significant anxiety and safety feelings. Multiple sclerosis. pp. 1667-1668. [Online]. 
  
Back to record